First Time Loading...

Sihuan Pharmaceutical Holdings Group Ltd
HKEX:460

Watchlist Manager
Sihuan Pharmaceutical Holdings Group Ltd Logo
Sihuan Pharmaceutical Holdings Group Ltd
HKEX:460
Watchlist
Price: 0.63 HKD 10.53% Market Closed
Updated: May 3, 2024
Section:
 

Wall Street
Price Targets

Price Targets Summary
Sihuan Pharmaceutical Holdings Group Ltd

Wall Street analysts forecast Sihuan Pharmaceutical Holdings Group Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Sihuan Pharmaceutical Holdings Group Ltd is 2.74 HKD .

Lowest Forecast
Wall Street Target
Not Available
Average Forecast
Wall Street Target
2.74 HKD
335% Upside
Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
2.74 HKD
335% Upside
Highest
Price Target
Not Available
Sihuan Pharmaceutical Holdings Group Ltd Competitors:
Price Targets
SUPN
Supernus Pharmaceuticals Inc
36% Upside
ROG
Roche Holding AG
29% Upside
C
CU6
Clarity Pharmaceuticals Ltd
5% Upside
VLS
Vita Life Sciences Ltd
62% Downside
SUPN
Supernus Pharmaceuticals Inc
36% Upside
ROG
Roche Holding AG
29% Upside
C
CU6
Clarity Pharmaceuticals Ltd
5% Upside
VLS
Vita Life Sciences Ltd
62% Downside
PBP
Probiotec Ltd
8% Upside
300026
Tianjin Chase Sun Pharmaceutical Co Ltd
454% Upside
L
503
Lansen Pharmaceutical Holdings Ltd
78% Downside
GSK
GlaxoSmithKline PLC
12% Upside

Revenue
Forecast

Revenue Estimate
Sihuan Pharmaceutical Holdings Group Ltd

For the last 8 years the compound annual growth rate for Sihuan Pharmaceutical Holdings Group Ltd's revenue is -6%. The projected CAGR for the next 2 years is 17%.

-6%
Past Growth
17%
Estimated Growth
Estimates Accuracy
-12%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Sihuan Pharmaceutical Holdings Group Ltd

For the last 8 years the compound annual growth rate for Sihuan Pharmaceutical Holdings Group Ltd's operating income is -64%.

-64%
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-19%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Sihuan Pharmaceutical Holdings Group Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
14%
Average Beat
What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Sihuan Pharmaceutical Holdings Group Ltd's stock price target?
Price Target
2.74 HKD

According to Wall Street analysts, the average 1-year price target for Sihuan Pharmaceutical Holdings Group Ltd is 2.74 HKD .

What is Sihuan Pharmaceutical Holdings Group Ltd's Revenue forecast?
Projected CAGR
17%

For the last 8 years the compound annual growth rate for Sihuan Pharmaceutical Holdings Group Ltd's revenue is -6%. The projected CAGR for the next 2 years is 17%.

ALPHA SPREAD
Join more than 133,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.